Are you an Ozempic user, or considering starting on the drug? You may want to read this. Recent research is cause for concern ...

Novo Nordisk's shares plummeted due to disappointing trial results for CagriSema, with patients achieving only 22.7% weight ...

I'm cautious about Novo Nordisk's short-term prospects due to the recent selloff, but see long-term potential with high ...

A dietetics professor explains who should and should not embrace the latest weight-loss drugs. Holiday weight gain hits home ...

Researchers have redefined obesity, emphasizing the impact of excess adiposity on organ and tissue function rather than ...

In Tuesday's issue of The Lancet Diabetes & Endocrinology, dozens of international medical experts and people with lived ...

As I mingled with socialites, I noticed a curious trend - everyone looked noticeably slimmer. It didn't take long to uncover ...

Ozempic, approved for Type 2 diabetes, has gained fame for its weight-loss properties, especially among celebrities. Despite its rising popularity, ex ...

The most negatively impacted sectors are frozen, refrigerated, general food and beverages. Circana found GLP-1 users’ monthly ...

Anesthesiologist Joshua Hackett grew up in Chico, attended Chico State, and now practices in Humboldt County. He has a ...

Canadian public and private insurers have balked at covering certain medication for weight-loss, but that might change as the ...

Ozempic and similar drugs are advertised all over the place, from television ads, public transit, audio streaming platforms ...